Editorial
Published on 23 Apr 2025
Editorial: Beyond psilocybin: exploring the clinical potential of alternative and novel psychedelics
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2025.1600812
- 554 views
Type at least 3 characters
551 articles
Systematic Review
Published on 15 Apr 2025
Efficacy of perioperative esketamine on postoperative depression: a systematic review and meta-analysis
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2025.1476449
- 406 views
Case Report
Published on 09 Apr 2025
Acute myasthenia caused by lithium: a case report
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2025.1467267
- 381 views
Opinion
Published on 08 Apr 2025
Harnessing neuroplasticity with psychoplastogens: the essential role of psychotherapy in psychedelic treatment optimization
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2025.1565852
- 1,187 views
Review
Accepted on 04 Apr 2025
BENZOS (AS) NEEDED: RESEARCH INTO AS-NEEDED AND INTERMITTENT BENZODIAZEPINES FOR ANXIETY IS REQUIRED FOR COMPREHENSIVE BEST PRESCRIBING PRACTICES
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2025.1569416
Case Report
Accepted on 01 Apr 2025
The role of dulaglutide in the treatment of alcohol use disorder: a case report
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2025.1420316
- 124 views
Original Research
Published on 27 Mar 2025
Estimating the incidence of actionable drug-gene interactions in Japanese patients with major depressive disorder
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2025.1542000
- 588 views
Editorial
Published on 14 Mar 2025
Editorial: Safety and side effects of psychotropic medications, volume III
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2025.1562008
- 507 views
Mini Review
Published on 12 Mar 2025
Could antidepressants increase mood and immunity at the same time?
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2025.1340179
- 945 views
Original Research
Accepted on 07 Mar 2025
Postmarketing Safety Assessment of the Novel Postpartum Depression Drug, Zuranolone: Evidence from Real-World Pharmacovigilance Analysis Based on the FDA Adverse Event Reporting System (FAERS)
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2025.1517773
- 156 views
Brief Research Report
Published on 05 Mar 2025
Patterns in (es)citalopram prescriptions to Medicaid and Medicare patients in the United States: the potential effects of evergreening
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2025.1450111
- 583 views
Original Research
Published on 04 Mar 2025
Long-term effectiveness, adherence and safety of twice-yearly paliperidone-palmitate long acting-injectable in patients with schizophrenia in Europe: 2-year mirror-image data from the paliperdone-2 per year study (P2Y)
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2025.1540213
- 1,179 views
Original Research
Published on 03 Mar 2025
Exposure and response prevention versus risperidone for the treatment of tic disorders: a randomized controlled trial
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2024.1360895
- 1,054 views
Editorial
Published on 13 Feb 2025
Editorial: Case reports in psychopharmacology, volume II
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2025.1554037
- 529 views
Original Research
Published on 05 Feb 2025
Lurasidone uses and dosages in Spain: RETROLUR, a real-world retrospective analysis using artificial intelligence
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2024.1506142
- 1,367 views
Case Report
Published on 03 Feb 2025
Treatment of neuropathic pain with repeated low-dose MDMA: a case report
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2025.1513022
- 2,745 views